Concepedia

Alessandro Di Federico

AD

41

Publications

1.4K

Citations

20

H-Index

2005

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

University of Bologna

Azienda USL di Bologna

Harvard University

Brigham and Women's Hospital

Alessandro Di Federico is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2005–2025

41

Publications

41

Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non–Small-Cell Lung Cancer

Biagio Ricciuti, Giuseppe Lamberti, Sreekar Reddy Puchala et al. · Journal of Clinical Oncology · 2024 · 100 citations · Full text

STK11/LKB1 and KEAP1 mutations in non-small cell lung cancer: Prognostic rather than predictive?

Alessandro Di Federico, Andrea De Giglio, Claudia Parisi et al. · European Journal of Cancer · 2021 · 98 citations · Full text

, , +9

Atezolizumab-bevacizumab plus Y-90 TARE for the treatment of hepatocellular carcinoma: preclinical rationale and ongoing clinical trials

Alessandro Di Federico, Alessandro Rizzo, Riccardo Carloni et al. · Expert Opinion on Investigational Drugs · 2021 · 97 citations

rev.ng: a unified binary analysis framework to recover CFGs and function boundaries

Alessandro Di Federico, Mathias Payer, Giovanni Agosta · 2017 · 79 citations · Full text

, , +24

Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC

Joao V. Alessi, Arielle Elkrief, Biagio Ricciuti et al. · Journal of Thoracic Oncology · 2023 · 79 citations · Full text

, , +7

Rows per page

1–5 of 41